期刊文献+

血液透析治疗糖尿病终末期肾病临床体会 被引量:9

The clinical experience of hemodialysis treatment of diabetic ESRD
下载PDF
导出
摘要 目的探讨糖尿病肾病终末期患者的血液透析时机及并发症的防治。方法观察糖尿病终末期肾病(ESDN)及非糖尿病终末期肾病(NOR-ESDN)血液透析患者首次透析前血尿素氮、肌酐以及透析期间并发症、存活率。结果糖尿病终末期肾病血透患者的存活率较非糖尿病终末期肾病血透患者短,心血管并发症及感染并发症较NOR-ESDN血透患者发生多。结论 ESDN患者透析时机的选择应早于NOR-ESDN患者,应积极预防和控制并发症。 Objective Explore the prevention and treatment of diabetic nephropathy in patients with end-stage hemodialysis timing and complications. Methods Observed in diabetic end-stage renal disease and non-diabetic end-stage kidney disease in hemodialysis patients first pre-dialysis blood urea nitrogen, creatinine, and during dialysis complications, the survival rate. Results Diabetic ESRD hemodialysis patients with surviv- al than non-diabetic ESRD hemodialysis patients, cardiovascular complications and infection complications than NOR-ESDN hemodialysis patients. Conclusion And of ESDN dialysis timing selection should be earlier than the NOR-ESDN patients should actively prevent and control complications.
作者 李军 曹德文
机构地区 辽源市中心医院
出处 《中国实用医药》 2012年第35期37-38,共2页 China Practical Medicine
关键词 糖尿病肾病 血液透析 生存率 透析时机 并发症 Diabetic nephropathy Hemodialysis Survival rate Dialysis timing Complication
  • 相关文献

参考文献5

二级参考文献17

  • 1程虹.糖尿病肾病的诊断与治疗[J].西藏医药,2004,25(4):15-19. 被引量:11
  • 2潘长玉,金文胜.2型糖尿病流行病学[J].中华内分泌代谢杂志,2005,21(5). 被引量:168
  • 3林善锬 主编.糖尿病肾病[A]..当代肾脏病学[C].上海:上海科技教育出版社,2001.581-593.
  • 4TERADA I,HYDE C. The SF-36:an instrument for measuring quality of life in ESRD patients[J]. Edtna Erca J, 2002,28 (2):73-76.
  • 5SANTORO A, MANCINI E, PAOLINI F, et al. Blood volume regulation hemodialysis[J]. Am J Kidney Dis, 1998,32(5) : 739-748.
  • 6SARNAK M J, LONG J, KING A J. Intravesicular formalolehyde instillation and renal complications [J ]. Clin Nephrol, 1999,51(2) :122-125.
  • 7Gandjour A,Lauterbach KW.An evidence-based disease-management program for patients with diabetic nephropathy.J Nephrol,2003,16:500 -510.
  • 8National Institutes of Health,NIDDK/DKUHD.Excertpts from the United States renal data system's.2003 annual data report:Stlas of end-stage renal disease in the United States.Am J Kidney Dis,2003,42:S226.
  • 9Pisoni RL,Young EW,Dykstra DM,et al.Vascular access use in Europe and the united states:Results from the DOPPS.Kidney Int,2002,61,305-316.
  • 10Stak AG,Bloembergen WE.A Cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.Am J Kidney Dis,2001,38:992-1000.

共引文献84

同被引文献91

引证文献9

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部